Available studies indicate Tirzepatide is a highly effective dual-agonist (GLP-1 + GIP) with an established FDA track record for glycemic control and weight loss
They are: CJC-1295 / Ipamorelin: stimulates pulsatile growth hormone release, which supports lean muscle preservation and fat metabolism over time
Study 3: IV safety (2025)
While anger is not listed as a common side effect in official prescribing information, emerging anecdotal accounts warrant closer examination of how these medications interact with mood regulation and neurotransmitter pathways
Morgante G, Orvieto R, Di Sabatino A, Musacchio MC, De Leo V
and 4hypertonic flexor and extensor muscles, clonus and hyperreflexia, the latter including a positive curling reaction